The Sunbelt Melanoma Trial.
The Sunbelt Melanoma Trial is a prospective randomized trial to evaluate the role of lymph node dissection and adjuvant interferon alfa-2b for patients with early lymph node metastases.
McMasters
K M
KM
Department of Surgery, University of Louisville, J. Graham Brown Cancer Center, Kentucky 40202, USA. kelly.mcmasters@nortonhealthcare.org
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008545:Melanoma / Q000473:pathology / Q000628:therapy*; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging / Q000379:methods; D011446:Prospective Studies; D012333:RNA, Messenger / Q000032:analysis; D011994:Recombinant Proteins; D020133:Reverse Transcriptase Polymerase Chain Reaction; D021701:Sentinel Lymph Node Biopsy / Q000379:methods; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy*
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D012333:RNA, Messenger; D011994:Recombinant Proteins